HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. raised its stake in HealthEquity, Inc. (NASDAQ:HQY) by 1.1% in the 4th quarter, Holdings Channel reports. The institutional investor owned 8,976,091 shares of the company’s stock after buying an additional 99,624 shares during the period. Vanguard Group Inc. owned 0.10% of HealthEquity worth $861,256,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of HQY. Smartleaf Asset Management LLC grew its holdings in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after purchasing an additional 98 shares during the period. Louisiana State Employees Retirement System boosted its holdings in HealthEquity by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after purchasing an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund grew its stake in shares of HealthEquity by 0.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock valued at $1,706,000 after buying an additional 100 shares during the period. State of Michigan Retirement System increased its holdings in shares of HealthEquity by 0.5% during the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock worth $1,988,000 after buying an additional 100 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of HealthEquity by 0.6% during the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company’s stock valued at $1,850,000 after buying an additional 106 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.20% of the stock is owned by company insiders.

HealthEquity Stock Down 2.1 %

Shares of NASDAQ HQY opened at $86.96 on Friday. The stock has a market cap of $7.52 billion, a P/E ratio of 79.78, a PEG ratio of 1.60 and a beta of 0.62. The business’s fifty day simple moving average is $103.63 and its 200-day simple moving average is $96.06. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. JMP Securities increased their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. The Goldman Sachs Group reduced their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday. Barrington Research reaffirmed an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. Finally, KeyCorp reduced their price target on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Monday, March 24th. One analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $112.23.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.